Golparian D, Jacobsson S, Sanchez-Buso L, Bazzo ML, et al. GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility. J Antimicrob Chemother 2022;78:150-154.
PMID: 36308328